Fonte: Journal of Cachexia, Sarcopenia and Muscle. Nome do evento: Cachexia Conference. Unidade: ICB
Assuntos: PERDA DE PESO, NEUROPEPTÍDEOS, DOENÇAS METABÓLICAS, NEOPLASIAS DO COLON
ABNT
LIRA, Fabio et al. Neuropeptides, metabolic disorder and inflammation in colon cancer patients: contributing to the cachexia syndrome. Journal of Cachexia, Sarcopenia and Muscle. Milão: Society on Sarcopenia, Cachexia and Wasting Disorders. . Acesso em: 06 set. 2024. , 2011APA
Lira, F., Silvério, R., Oyama, L., Nascimento, C. O., Batista, M., Laviano, A., et al. (2011). Neuropeptides, metabolic disorder and inflammation in colon cancer patients: contributing to the cachexia syndrome. Journal of Cachexia, Sarcopenia and Muscle. Milão: Society on Sarcopenia, Cachexia and Wasting Disorders.NLM
Lira F, Silvério R, Oyama L, Nascimento CO, Batista M, Laviano A, Rossi-Fanelli F, Alcântara P, Otoch J, Seelaender MCL. Neuropeptides, metabolic disorder and inflammation in colon cancer patients: contributing to the cachexia syndrome. Journal of Cachexia, Sarcopenia and Muscle. 2011 ; 2( 4): 209-261.[citado 2024 set. 06 ]Vancouver
Lira F, Silvério R, Oyama L, Nascimento CO, Batista M, Laviano A, Rossi-Fanelli F, Alcântara P, Otoch J, Seelaender MCL. Neuropeptides, metabolic disorder and inflammation in colon cancer patients: contributing to the cachexia syndrome. Journal of Cachexia, Sarcopenia and Muscle. 2011 ; 2( 4): 209-261.[citado 2024 set. 06 ]